Clinical Trial Update: Biomarker Guided Treatment in DLBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating biomarker-guided treatment in Diffuse Large B Cell Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN